Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:THRD

Third Harmonic Bio (THRD) Stock Price, News & Analysis

Third Harmonic Bio logo

About Third Harmonic Bio Stock (NASDAQ:THRD)

Advanced Chart

Key Stats

Today's Range
$5.44
$5.51
50-Day Range
N/A
52-Week Range
N/A
Volume
218,713 shs
Average Volume
168,074 shs
Market Capitalization
$245.96 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.00
Consensus Rating
Hold

Company Overview

Third Harmonic Bio Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
5th Percentile Overall Score

THRD MarketRank™: 

Third Harmonic Bio scored higher than 5% of companies evaluated by MarketBeat, and ranked 923rd out of 937 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Third Harmonic Bio has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 3 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Third Harmonic Bio has received no research coverage in the past 90 days.

  • Read more about Third Harmonic Bio's stock forecast and price target.
  • Earnings Growth

    Earnings for Third Harmonic Bio are expected to decrease in the coming year, from ($1.08) to ($1.09) per share.

  • Price to Book Value per Share Ratio

    Third Harmonic Bio has a P/B Ratio of 0.86. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    6.64% of the float of Third Harmonic Bio has been sold short.
  • Short Interest Ratio / Days to Cover

    Third Harmonic Bio has a short interest ratio ("days to cover") of 2.8, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Third Harmonic Bio has recently increased by 3.50%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Third Harmonic Bio does not currently pay a dividend.

  • Dividend Growth

    Third Harmonic Bio does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    6.64% of the float of Third Harmonic Bio has been sold short.
  • Short Interest Ratio / Days to Cover

    Third Harmonic Bio has a short interest ratio ("days to cover") of 2.8, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Third Harmonic Bio has recently increased by 3.50%, indicating that investor sentiment is decreasing.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for Third Harmonic Bio this week, compared to 1 article on an average week.
  • Search Interest

    Only 1 people have searched for THRD on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Third Harmonic Bio insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 7.80% of the stock of Third Harmonic Bio is held by insiders.

  • Percentage Held by Institutions

    93.95% of the stock of Third Harmonic Bio is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Third Harmonic Bio's insider trading history.
Receive THRD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Third Harmonic Bio and its competitors with MarketBeat's FREE daily newsletter.

THRD Stock News Headlines

Treasury Secretary Bessent Is Betting Big on Gold
When the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gold analyst believes Warren Buffett is preparing to follow suit… and he’s identified one gold miner big enough to absorb a portion of Buffett’s $330B cash pile. A key filing could confirm it by August 15th — and early investors may want to act now.
See More Headlines

THRD Stock Analysis - Frequently Asked Questions

Third Harmonic Bio, Inc. (NASDAQ:THRD) released its quarterly earnings data on Thursday, May, 8th. The company reported ($0.35) EPS for the quarter, missing analysts' consensus estimates of ($0.26) by $0.09.

Third Harmonic Bio (THRD) raised $185 million in an IPO on Thursday, September 15th 2022. The company issued 10,900,000 shares at $16.00-$18.00 per share.

Based on aggregate information from My MarketBeat watchlists, some other companies that Third Harmonic Bio investors own include NVIDIA (NVDA), Broadcom (AVGO), Meta Platforms (META), Arista Networks (ANET), Adobe (ADBE), ServiceNow (NOW) and e.l.f. Beauty (ELF).

Company Calendar

Last Earnings
5/08/2025
Today
7/16/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
N/A
Current Symbol
NASDAQ:THRD
CIK
921051
Fax
N/A
Employees
N/A
Year Founded
N/A

Price Target and Rating

High Price Target
$5.00
Low Price Target
$5.00
Potential Upside/Downside
-8.3%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
3 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.62)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$45.47 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-19.27%
Return on Assets
-18.67%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
54.10
Quick Ratio
54.10

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$6.33 per share
Price / Book
0.86

Miscellaneous

Outstanding Shares
45,130,000
Free Float
42,465,000
Market Cap
$245.96 million
Optionable
Optionable
Beta
2.12
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (NASDAQ:THRD) was last updated on 7/16/2025 by MarketBeat.com Staff
From Our Partners